今海國際(02225.HK)更改部份上市所得款項用途
今海國際(02225.HK)公布,就有關上市所得,目前未動用所得款項淨額約8,080萬元。
公司計劃將部份未動用資金,約1,000萬元用於在公開市場收購若干上市證券,以產生較豐厚的短期收益及提高公司閒置現金的收益率。同時擬動用580萬元償還貸款。
而就原訂項目,包括增購外籍工人宿舍,及增購10輛卡車,公司希望可於未來12個月內覓得符合其業務需求且價格合理之物業,同時預期在今年年底,及明年年中前,分別增購3輛及4輛卡車。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.